Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-26-071862
Filing Date
2026-02-25
Accepted
2026-02-25 16:39:51
Documents
21
Effectiveness Date
2026-02-25

Document Format Files

Seq Description Document Type Size
1 S-3ASR d274489ds3asr.htm S-3ASR 403289
2 EX-1.2 d274489dex12.htm EX-1.2 207271
3 EX-4.4 d274489dex44.htm EX-4.4 292190
4 EX-5.1 d274489dex51.htm EX-5.1 27766
5 EX-23.1 d274489dex231.htm EX-23.1 1815
6 EX-FILING FEES d274489dexfilingfees.htm   iXBRL EX-FILING FEES 39840
7 GRAPHIC g274489g00z04.jpg GRAPHIC 37612
8 GRAPHIC g274489g00z33.jpg GRAPHIC 44400
9 GRAPHIC g274489g0219120428715.jpg GRAPHIC 2457
10 GRAPHIC g274489g0219160941105.jpg GRAPHIC 4213
  Complete submission text file 0001193125-26-071862.txt   1245988

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT d274489dexfilingfees_htm.xml XML 20408
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-293750 | Film No.: 26679522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)